The AHS/Smith/Mraiche Boondoggles are messy, so how about we dive in from a different angle out of all these allegations. Weāre going to take a peek at this unfolding story from todayās main subject: Jitendra Prasad - middle-man, extraordinaire. Prasad, a man who allegedly wears so many team colours that he falls under extreme pressure; a bit like sitting right in the centre of a fault line between massive tectonic plates. At some point the pressure was so much that he ends up raising suspicion on himself and the contracts he participated in.
With Mentzelopoulosā claim in mind, both the former CEO, her colleagues, and the AHS Board were so concerned with these contracts that a third party law firm was retained to investigate. Ultimately, and a pillar of the allegations, is that Alberta Health Minister LaGrange fired the CEO, and the AHS Board, and ordered the investigations closed before any results could come out.
Netizens can see some context from āAHS made $28-million prepayment for imported drugs two weeks after telling hospitals not to use themā, by Matthew Black. We learn that back in July 10, 2023, AHS had already issued instructions to cease using Parol brand acetaminophen. Yet, on July 26, 2023, āAHS issued the prepayment for years three, four, and five of the contract it signed in December of 2022 for medication imported from Turkish company Atabay.ā
>In its statement, AHS said it was informed at the time that the prepayment was required to secure āfavourable pricing, support production adjustments, ensure uninterrupted availability, and enable manufacturer investments to meet Health Canada requirements.ā
>It adds, āAHSā understanding is that MHCare has been awaiting Health Canada approval for these additional products.ā
>Applications for drug approvals are tracked in a publicly available Health Canada database, but it contains no entry for either Atabay or MHCare.
Whatās alleged in the claim at this time was Jitendra Prasad was the middle-man between Alberta Health, AHS, and MHCare Medical. As noted, Prasad had a
>āā¦MHCare email address in November 2022 just before the then Minister of Health directed AHS to enter into a contract with MHCare for a $70 million childrenās acetaminophen purchase order and supply agreement, and Prasad may also have been retained or otherwise contracted by persons who were involved with the CSFs and other AHS procurement contracts in and after 2022.ā
Prasadās work history was summarized as bouncing between AHS as an employee or a contractor, and potentially retained or contracted by MHCare and other Chartered Surgical Facilities or all the above possibly.
>āPrasad retired briefly from AHS in April 2022 before becoming a contractor for AHS , and then returned as an AHS employee in the position of Chief Program Officer, and later Special Advisor, for AHS Contracts, Procurement, and Supply Management (āCPSMā) from October 2022 to December 2023, before then being seconded from AHS to Alberta Healthā¦ā
By October of 2024, AHS is alerted to media inquiry about the childrenās acetaminophen issue, and received media questions about transactions between AHS, MHCare Medical, and other entities associated with Sam Mraiche. Alberta Health directed Mentzelopoulos to refer these questions to Prasad because he āwas the person who negotiated the AHS purchase contract for childrenās acetaminophen and knew āeverythingā about the deal.ā
Whatās alleged is this media interest, and Prasadās response, would be the canary in the coal mine that accelerated everything.
>āMentzelopoulos received the proposed reply drafted by Prasad and apparently reviewed by staff in Alberta Health and by the Premierās Office. The response indicated that AHS did not have any contract with MHCare, and that the childrenās ibuprofen / acetaminophen contract had been between AHS and a Turkish company (Atabay Pharmaceuticals), a statement that Mentzelopoulos knew was false.ā
Netizens should read the claim for themselves as the details are remarkable. But, by November 2024, an external forensic audit was started by a third party law firm. Even if Mentzelopoulos did not telegraph her moves or share them widely, news of the investigation allegedly spread.
>On December 16, 2024, Mentzelopoulos attended a reception at the AIMCO offices and was approached by Kate White, Deputy Minister of Treasury Board and Finance. Ms. White asked Mentzelopoulos what was going on at Alberta Health and specifically referred to an investigation involving Prasad and ākickbacksā (her phrase). Mentzelopoulos declined to discuss any specifics but was surprised to learn that officials from Treasury Board and Finance knew about the ongoing investigation
Others would approach the former CEO, but the point of these allegations - if proven - is simple: Danielle Smith knew.
#EthicalFading#comment#AbLeg #AbPoli #CdnPoli 105
https://edmontonjournal.com/news/politics/alberta-health-services-mhcare-payment